Publications

CIBMTR>
Resources>
Publications

Researcher Reviews Publications

CIBMTR Publication List

Since 1972, using CIBMTR data and statistical resources has resulted in more than 1,800 publications.

CIBMTR also makes its publication analysis datasets freely available to the public for secondary analysis while safeguarding participants' privacy and protecting confidential and proprietary data.

View Publicly Available Datasets

Filter Results

Skip to Results Listing clear all

Keywords

Journal

Program/Committee

clear

Acute Leukemia(76)

Bioinformatics(159)

BIOSTATS(148)

BMT CTN(178)

Cellular Immunotherapy for Cancer (Phasing Out)(19)

Chronic Leukemia(46)

CIBMTR(170)

Coordinating Center(18)

Corporate Program(4)

Donor and Recipient Health Services(54)

Graft Sources and Manipulation(53)

Graft-versus-Host Disease(53)

Health Policy and Psychosocial Issues(14)

HSP/OPA(58)

IBMTR(209)

Immunobiology(175)

Infection and Immune Reconstitution(26)

International Studies(4)

Late Effects and Quality of Life(1)

Lymphoma(85)

Morbidity, Recovery and Survivorship(125)

NMDP(101)

Non-Malignant Diseases(57)

OTHER(12)

Pediatric Cancer(30)

Plasma Cell Disorders(61)

RCI BMT(10)

RETIRED - Health Services and International Studies(14)

Statistical Center(21)

See All

See Less

View Results

Browse Publications

Sort by:

Alphabetical
Sort Date "Newest First"
Sort Date "Oldest First"
Most Popular
Highest Rated
ePubDate Ascending
ePubDate Descending

Please wait while we gather your results.

Results Updated

20 Results Listed

Page 1 of 50
Next

Skip to Filters

2025 | JCO Oncology Practice

Erratum: Rapid donor identification improves survival in high-risk first-remission patients with acute myeloid leukemia.

Authors:

Pagel JM, Othus M, Garcia-Manero G, Fang M, Radich JP, Rizzieri DA, Marcucci G, Strickland SA, Litzow MR, Savoie ML, Spellman SR, Confer DL, Chell JW, Brown M, Medeiros BC, Sekeres MA, Lin TL, Uy GL, Powell BL, Bayer R-L, Larson RA, Stone RM, Claxton D, Essell J, Luger SM, Mohan SR, Moseley A, Erba HP, Appelbaum FR

2025 | Blood Advances

Transplant outcomes Using Older Matched Sibling Donors Compared to Young Alternative Donors: A CIBMTR Analysis

Authors:

Nath K, Zhang MJ, Bye M, Abid MB, Benjamin C, Betts BC, Bhatt NS, Arrieta-Bolaños E, Bolon YT, Gadalla SM, Grunwald MR, Krem MM, Lee SJ, Marsh SGE, Martino R, Mehta PA, Milano F, Prestidge T, Saultz JN, Shaw BE, Spellman SR, Choe HK, Shaffer BC

2025 | American Journal of Human Genetics

Human leukocyte antigen variation is associated with cytomegalovirus serostatus in healthy individuals.

Authors:

Boquett JA, Sauter J, Schmidt AH, Maiers M, Hollenbach JA

2025 | American Journal of Hematology

Five-year real-world safety of Inotuzumab Ozogamicin before hematopoietic stem cell transplantation in B-cell precursor acute lymphoblastic leukemia.

Authors:

de Lima M, Kebriaei P, Lanza F, Cho C, Popradi G, Kaur M, Zhang MJ, Zhang F, Shah R, Vandendries E, Asomaning K, Dorman S, Stelljes M, Marks DI, Saber W

2025 | Journal for Immunotherapy of Cancer (JI...

Real-world outcomes with tisagenlecleucel in aggressive B-cell lymphoma: subgroup analyses from the CIBMTR registry.

Authors:

Landsburg DJ, Frigault MJ, Heim M, Foley SR, Hill B, Schofield G, Jacobson CA, Jaglowski S, Locke FL, Ram R, Riedell PA, Shah G, Popplewell LL, Tiwari R, Lim S, Majdan M, Masood A, Pasquini MC

2025 | Haematologica

Utilization of allogeneic hematopoietic stem cell transplantation among patients with newly diagnosed acute myeloid leukemia in California: a population-based linked dataset study.

Authors:

Meyer CL, Keegan THM, Brunson A, Auletta JJ, Morton LM, Wun T, Schonfeld SJ, Valcarcel B, Abrahão R, Yusuf R, Muffly L

2025 | Blood Advances

Impact of vein-to-vein time in patients with R/R LBCL treated with axicabtagene ciloleucel.

Authors:

Locke FL, Siddiqi T, Jacobson CA, Nikiforow S, Ahmed S, Miklos DB, Lin Y, Lunning MA, Hill BT, Ghobadi A, Hu ZH, Hemmer MT, Zoratti MJ, Vunnum S, Tsang J, Spooner C, Smith H, Fu C, Patel AR, Miao H, Shahani SA, Mirjah DL, Xu H, Pasquini MC

2025 | Transplantation and Cellular Therapy

The association of HLA-E ligand and NKG2 receptor variation with relapse and mortality after haploidentical related donor transplantation.

Authors:

Petersdorf EW, McKallor C, Malkki M, Hsu K, He M, Spellman SR, Gooley T, Stevenson P

2025 | Blood

Measurable residual disease and posttransplantation gilteritinib maintenance for patients with FLT3-ITD-mutated AML.

Authors:

Lewis MJ, Hamadani M, Logan BR, Jones RJ, Singh AK, Litzow MR, Wingard JR, Papadopoulos EB, Perl AE, Soiffer RJ, Ustun C, Ueda Oshima M, Uy GL, Waller EK, Vasu S, Solh MM, Mishra A, Muffly L, Kim HJ, Stelljes M, Najima Y, Onozawa M, Thomson Kj, Nagler A, Wei AH, Marcucci G, Chen C, Hasabou N, Rosales M, Hill JE, Gill SC, Nuthethi R, King D, Mendizabal A, Devine SM, Horowitz MM, Chen YB

2025 | Journal of Clinical Oncology

Improved patient-reported outcomes with post-transplant cyclophosphamide: A quality-of-life evaluation and 2-year outcomes of BMT CTN 1703.

Authors:

Holtan SG, Bolanis-Meade J, Al Malki MM, Wu J, Kitko C, Reshef R, Rezvani AR, Shaffer BC, Solh MM, Yao JM, Runaas L, Elmariah H, Larkin KT, El Jurdi N, Gooptu M, Loren AW, Hall AC, Alousi AM, Jamy O, Clark W, Kean L, Bhatt AS, Perales MA, Applegate K, Efebera YA, Leifer E, Jones RJ, Horowitz MM, Mattila D, Saber W, Hamadani M, Martens MJ

2025 | Transplantation and Cellular Therapy

Donor type does not impact late graft failure following reduced-intensity allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis.

Authors:

Hickey CL, Zhang M, Allbee-Johnson M, Romee R, Majhail NS, Malki M, Antin JH, Benjamin CL, Bredeson C, Chhabra S, Grunwald MR, Inamoto Y, Kanakry CG, Milano F, Soiffer RJ, Spellman SR, Solomon SR, Brunstein CG, Cutler C

2024 | Blood Advances

Outcomes of older adults and frail patients receiving idecabtagene vicleucel: a CIBMTR study.

Authors:

Akhtar OS, Oloyede T, Brazauskas R, Afrough A, Hashmi H, Sidana S, Ahmed N, Bye M, Hansen DK, Ferreri CJ, Dhakal B, Dhanda DS, Harrison MJ, Kitali A, Landau HJ, Mirza A, Patel J, Patwardhan P, Qazilbash MH, Patel KK, Nishihori T, Ganguly S, Gowda L, Anderson LD, Pasquini MC, Usmani SZ, Freeman CL

2024 | Clinical Trials

Sequential monitoring of time-to-event safety endpoints in clinical trials.

Authors:

Martens MJ, Lian Q, Geller N, Liefer ES, Logan B

2024 | Cytotherapy

Harnessing global HLA data for enhanced patient matching in iPSC haplobanks.

Authors:

Maiers M, Sullivan S, McClain C, Leonhard-Melief C, Turner ML, Turner D

2024 | Bone Marrow Transplantation

Role of the CIBMTR biorepository and registry in precision transplantation research.

Authors:

Guerrettaz RD, Spellman SR, Page KM

2024 | Clinical Transplantation

Novel scoring system for ranking hematopoietic stem cell transplantation.

Authors:

Baxter-Lowe LA, Wang T, Kuxhausen M, Spellman SR, Maiers M, Lee SJ, Saultz J, Arrieta-Bolaños E, Gadalla SG, Bolon Y, Betts BC

2024 | Bone Marrow Transplantation

Measurable residual mutated IDH1 before allogeneic transplant for acute myeloid leukemia.

Authors:

Gui G, Ravindra N, Hegde PS, Andrew G, Mukherjee D, Wong ZC, Auletta JJ, El Chaer F, Chen EC, Chen Y, Corner A, Devine SM, Iyer SG, Jimenez Jimenez AM, De Lima MJG, Litzow MR, Kebriaei P, Saber W, Spellman SR, Zeger S, Page KM, Dillon LW, Hourigan CS

2024 | Journal of Clinical Oncology

Reply to: disparities in allograft access in the era of post-transplant cyclophosphamide-based mismatched unrelated donor transplantation.

Authors:

Shaffer BC, Gooptu M, DeFor T, Spellman SR, Stefanski HE, Shaw BE, Auletta JJ, Devine SM, Jimenez AM, Al Malki MM

2024 | Journal of Pediatric Hematology/Oncology

Why are higher cd34+ cell doses associated with improved outcomes among pediatric patients undergoing autologous hematopoietic stem cell transplant for central nervous system tumors - but not for high-risk neuroblastoma?

Authors:

Knight TE, Broglie L, Sharma A, Qayed M, Yanik GA

2024 | Journal of Hematology & Oncology

Prognostic impact of donor mitochondrial genomic variants in myelodysplastic neoplasms after stem-cell transplantation.

Authors:

Dong J, Arsang-Jang S, Zhang T, Chen Z, Bolon Y, Spellman SR, Urrutia R, Auer P, Saber W

Page 1 of 50
Next